Actions of the anti-cancer drug suberoylanilide hydroxamic acid (SAHA) on human breast cancer cytoarchitecture in silicon microstructures

Biomaterials ◽  
2010 ◽  
Vol 31 (27) ◽  
pp. 7043-7050 ◽  
Author(s):  
Jeannine S. Strobl ◽  
Mehdi Nikkhah ◽  
Masoud Agah
Keyword(s):  
Breast Cancer ◽  
Human Breast Cancer ◽  
Hydroxamic Acid ◽  
Cancer Drug ◽  
Suberoylanilide Hydroxamic Acid ◽  
Human Breast ◽  
Anti Cancer ◽  
Silicon Microstructures

scholarly journals Activity of Suberoylanilide Hydroxamic Acid Against Human Breast Cancer Cells with Amplification of Her-2

2005 ◽  
Vol 11 (17) ◽  
pp. 6382-6389 ◽  
Author(s):  
Purva Bali ◽  
Michael Pranpat ◽  
Ramona Swaby ◽  
Warren Fiskus ◽  
Hirohito Yamaguchi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Cells ◽  
Human Breast Cancer ◽  
Hydroxamic Acid ◽  
Breast Cancer Cells ◽  
Suberoylanilide Hydroxamic Acid ◽  
Human Breast Cancer Cells ◽  
Human Breast ◽  
Her 2

Molecular Mechanisms of Thymoquinone as Anticancer agent

2020 ◽  
Vol 23 ◽  
Author(s):  
Fatma Ismail Alhmied ◽  
Ali Hassan Alammar ◽  
Bayan Mohammed Alsultan ◽  
Marooj Alshehri ◽  
Faheem Hyder Pottoo
Keyword(s):  
Breast Cancer ◽  
Cell Cycle ◽  
Cell Cycle Arrest ◽  
Human Breast Cancer ◽  
Phase Cell ◽  
Cycle Phase ◽  
Human Breast ◽  
Cycle Arrest ◽  
Phase Arrest ◽  
Anti Cancer

Abstract:: Thymoquinone (TQ), the bioactive constituent of Nigella Sativa seeds is a well-known natural compound for the management of several types of cancers. The anti-cancer properties of thymoquinone are thought to be operated via intervening with various oncogenic pathways including cell cycle arrest, prevention of inflammation and oxidative stress, induction of invasion, metastasis, inhibition of angiogenesis, and apoptosis. As well as up-regulation and down-regulation of specific tumor suppressor genes and tumor promoting genes, respectively. Proliferation of various tumor cells is inhibited by TQ via induction of cell cycle arrest, disruption of the microtubule organization, and down regulating cell survival protein expression. TQ induces G1 phase cell cycle arrest in human breast cancer, colon cancer and osteosarcoma cells through inhibiting the activation of cyclin E or cyclin D and up-regulating p27and p21 a cyclin dependent kinase (Cdk) inhibitor. TQ concentration is a significant factor in targeting a particular cell cycle phase. While high concentration of TQ induced G2 phase arrest in human breast cancer (MCF-7) cells, low concentration causes S phase arrest. This review article provides mechanistic insights into the anti-cancer properties of thymoquinone.

Sign in / Sign up

Export Citation Format

Share Document